COPD

The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for the chronic obstructive pulmonary disease, which is causes breathing difficulties.

Review: Exercise Endurance Could Be Key Tool to Track COPD Treatment Response

January 20th 2022, 3:00pm

Article

Patients whose endurance increases will likely have a higher quality of life and ability to carry out daily functions, the authors said.

Study: Excess Iron Linked With COPD Exacerbation

January 18th 2022, 2:30pm

Article

Evidence suggests higher levels of iron in pulmonary macrophages heightens the risk of infectious exacerbations.

Study: Total Airway Count Can Be Used to Measure Pulmonary Decline in COPD

January 15th 2022, 3:15pm

Article

The research suggests a computed tomography-readable biomarker could help clinicians better understand individual cases of chronic obstructive pulmonary disease.

At-Home Interventions Significantly Cut Readmission Rates in COPD, Study Finds

January 10th 2022, 4:30pm

Article

The 30-day readmission rate among patients receiving post-hospitalization at-home interventions was roughly half the rate of a control group.

Review Outlines Potential for Noninvasive Ventilation in Patients With COPD, Other Conditions

January 8th 2022, 3:25pm

Article

As noninvasive ventilation grows in popularity, new research examines when the therapy works, and when clinicians should be cautious.

Patients in Remote Greenlandic Region Often Given COPD Medication Without Spirometry

January 5th 2022, 4:00pm

Article

The study points to the challenges of treating chronic obstructive pulmonary disease in a remote region in a country with a high smoking rate.

Top 5 Most-Read COPD Articles of 2021

January 1st 2022, 1:50pm

Article

The most-read chronic obstructive pulmonary disease (COPD) articles of the year covered use of inhaled corticosteroids, palliative care for advanced COPD, and off-label prescribing of COPD therapies.

Growing Acceptance of Cannabis Leads to Concern About Future COPD Cases, Says Dr Don Sin

December 27th 2021, 12:50pm

Video

With legalization of cannabis across much of the United States and all of Canada, Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital, has concerns about the effect of wider cannabis usage on chronic obstructive pulmonary disease (COPD) in future decades.

Dr Don Sin on Using Biomarkers and Genomics for COPD Prevention

December 20th 2021, 1:35pm

Video

Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital, discusses future possibilities for the prevention of chronic obstructive pulmonary disease (COPD) using new biomarker discoveries and genomic technology advancements.

Digital Inhalers for COPD, Asthma Are Tantalizing but More Research Is Needed, Review Says

December 18th 2021, 6:45pm

Article

Interest in the use of digital inhalers is growing, as they may provide real-world evidence about how patients monitor and treat their chronic obstructive pulmonary disease (COPD) and asthma at home, but additional questions need to be answered, according to a recent review.